Royalty Pharma RPRX
NASDAQ RPRX
$63.99 +0.11 (+0.17%)
As of: Sep 4, 2026 · 3:59 PM EDT

Royalty Pharma (RPRX) Net Margin Growth (1y) (2020 - 2026)

Analysis

Royalty Pharma (RPRX) Net Margin Growth (1y) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -185.00
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -763.00
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 529.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 4,168.00
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 673.00
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 2,208.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - -392.00
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 29,636.00
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn 166.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -392.00
Mar 31, 2026 -219.00
Dec 31, 2025 90.00
Sep 30, 2025 -6,989.00
Jun 30, 2025 -2,017.00
Mar 31, 2025 7,720.00
Dec 31, 2024 -6,406.00
Sep 30, 2024 12,003.00
Jun 30, 2024 -2,910.00
Mar 31, 2024 -7,518.00
Dec 31, 2023 22,821.00
Sep 30, 2023 -1,567.00
Jun 30, 2023 -2,644.00
Mar 31, 2023 5,164.00
Dec 31, 2022 -11,715.00
Sep 30, 2022 57.00
Jun 30, 2022 -5,365.00
Mar 31, 2022 -496.00
Dec 31, 2021 -5,476.00
Sep 30, 2021 -7,808.00